The Chronic Refractory Gout Market is gaining strategic importance within the global rheumatology therapeutics landscape as unmet clinical needs persist among patients who fail to respond to conventional urate-lowering therapies. Valued at US$ 1,804.25 Million in 2024, the market is projected to expand at a CAGR of 10.23% from 2025 to 2032. The increasing prevalence of hyperuricemia, aging...
"Market Trends Shaping Executive Summary Febuxostat Market Size and Share
Febuxostat market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 7.9% in the above mentioned forecast period and is likely to reach the USD 1,662.16 million by 2029.
This Febuxostat Market report covers a...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt